Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children

被引:31
作者
McCoig, C
Castreujón, MM
Saavedre-Lozano, J
Castaño, E
Báez, C
Lanier, ER
Sáez-Llorens, X
Ramilo, O
机构
[1] Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX USA
[2] Hosp Nino, Panama City, Panama
[3] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
关键词
cytokines; human immunodeficiency virus; encephalopathy;
D O I
10.1097/01.inf.0000109247.67480.7a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The pathogenesis of HIV encephalopathy is poorly understood especially in children. Studies suggest that HIV replication and the release of proinflammatory mediators in the central nervous system contribute to the pathogenesis of HIV dementia in adults. Methods. Cerebrospinal fluid (CSF) and plasma samples from 23 HIV-infected children were longitudinally analyzed at Weeks 0, 8, 16 and 48 for HIV RNA and concentrations of the following proinflammatory mediators: monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-alpha, regulated upon activation, normal T cell expressed and secreted (RANTES), macrophage-inflammatory protein (MIP)-1-alpha, MIP-1-beta and matrix metalloproteinase-9 (MMP-9). Results. All 23 children had detectable concentrations of MCP-1 in the CSF at all time points evaluated. However, of the remaining of proinflammatory mediators measured in CSF at baseline, only a few children had detectable concentrations: tumor necrosis factor-alpha, n = 1; RANTES, n = 5; MMP-9, n = 9; MIP-1-alpha and MIP-1-beta, n = 0. A reduction from baseline to Week 48 was observed in CSF concentrations of MCP-1 and, among children with detectable values, MMP-9, which paralleled declines in CSF HIV RNA. Conclusion. These results suggest that MCP-1 and MMP-9 may be involved in the pathogenesis of central nervous system disease in HIV-infected children.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 16 条
[1]   Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage [J].
Brew, BJ ;
Pemberton, L ;
Cunningham, P ;
Law, MG .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :963-966
[2]  
Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO
[3]  
2-0
[4]   Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection [J].
Cooper, ER ;
Hanson, C ;
Diaz, C ;
Mendez, H ;
Abboud, R ;
Nugent, R ;
Pitt, J ;
Rich, K ;
Rodriguez, EM ;
Smeriglio, V .
JOURNAL OF PEDIATRICS, 1998, 132 (05) :808-812
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE NERVOUS-SYSTEM - PATHOGENETIC MECHANISMS [J].
EPSTEIN, LG ;
GENDELMAN, HE .
ANNALS OF NEUROLOGY, 1993, 33 (05) :429-436
[6]   Cytokines in the brain during viral infection: Clues to HIV-associated dementia [J].
Griffin, DE .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :2948-2951
[7]   β-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia [J].
Kelder, W ;
McArthur, JC ;
Nance-Sproson, T ;
McClernon, D ;
Griffin, DE .
ANNALS OF NEUROLOGY, 1998, 44 (05) :831-835
[8]   DETECTION OF AIDS VIRUS IN MACROPHAGES IN BRAIN-TISSUE FROM AIDS PATIENTS WITH ENCEPHALOPATHY [J].
KOENIG, S ;
GENDELMAN, HE ;
ORENSTEIN, JM ;
DALCANTO, MC ;
PEZESHKPOUR, GH ;
YUNGBLUTH, M ;
JANOTTA, F ;
AKSAMIT, A ;
MARTIN, MA ;
FAUCI, AS .
SCIENCE, 1986, 233 (4768) :1089-1093
[9]   Cerebrospinal fluid β chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1 [J].
Letendre, SL ;
Lanier, ER ;
McCutchan, JA .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :310-319
[10]   ENCEPHALOPATHY IN CHILDREN WITH PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
LOBATO, MN ;
CALDWELL, MB ;
NG, P ;
OXTOBY, MJ .
JOURNAL OF PEDIATRICS, 1995, 126 (05) :710-715